Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2593_Библиотеки_им_академика_М_И_Перельмана
.pdf
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
253.
Thanacoody R. Position paper update: whole bowel irrigation for
gastrointestinal decontamination of overdose patients. Clin Toxicol (Phila).
2015;53:5–12.
[No authors listed]. Position statement and practice guidelines on the use of
multi-dose activated charcoal in the treatment of acute poisoning. American
Academy of Clinical Toxicology; European Association of Poisons Centres
and Clinical Toxicologists. J Toxicol Clin Toxicol. 1999;37:731–751.
Vale JA. Clinical toxicology. Postgrad Med J. 1993;69:19–32.
Holz LE Jr, Holz PH. The black bottle. A consideration of the role of charcoal
in the treatment of poisoning in children. J Pediatr. 1963;63:306–314.
Neuvonen PJ, Olkkola KT. Oral activated charcoal in the treatment of
intoxications: role of single and repeated doses. Med Toxicol Adverse Drug
Exp. 1988;3:33–58.
Bond GR. The role of activated charcoal and gastric emptying in
gastrointestinal decontamination: a state-of-the-art review. Ann Emerg Med.
2002;39:273–286.
Harris CR, Filandrinos D. Accidental administration of activated charcoal into
the lung: aspiration by proxy. Ann Emerg Med. 1993;22:1470–1473.
Graff GR, Stark J, Berkenbosch JW, Holcomb GW 3rd, Garola RE. Chronic
lung disease after activated charcoal aspiration. Pediatrics. 2002;109:959–
961.
Elliot CG, Colby TV, Kelly TM, Hicks HG. Charcoal lung: bronchiolitis
obliterans after aspiration of activated charcoal. Chest. 1989;96:672–674.
Givens T, Holloway M, Wason S. Pulmonary aspiration of activated charcoal:
a complication of its misuse in overdose management. Pediatr Emerg Care.
1992;8:137–140.
Golej J, Boigner H, Burda G, Hermon M, Trittenwein G. Severe respiratory
failure following charcoal application in a toddler. Resuscitation.
2001;49:315–318.
Tomaszewski C. Activated charcoal—treatment or toxin? J Toxicol Clin
Toxicol. 1999;37:17–18.
Gazda-Smith E, Synhavsky A. Hypernatremia following treatment of
theophylline toxicity with activated charcoal and sorbitol. Arch Intern Med.
1990;150:689–692.
Allerton JP, Strom JA. Hypernatremia due to repeated doses of charcoalsorbitol. Am J Kidney Dis. 1991;17:581–584.
Tenebein M. Whole bowel irrigation as a gastrointestinal decontamination
procedure after acute poisoning. Med Toxicol Adverse Drug Exp. 1988;3:77–
84.
Hoffman RS, Goldfrank LR. The poisoned patient with altered
consciousness: controversies in the use of the “coma cocktail.” JAMA.
1995;274:562–569.
https://t.me/medicina_free
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
Trujillo MH, Guerrero J, Fragachan C, Fernandez MA. Pharmacologic
antidotes in critical care medicine: a practical guide for drug administration.
Crit Care Med. 1988;26:377–391.
Goldfrank LR, Hoffman RS. The cardiovascular effects of cocaine. Ann
Emerg Med. 1991;20:165–175.
Wrenn K, Smith BA, Slovis CM. Profound alkalemia during treatment of
tricyclic antidepressant overdose: a potential hazard of combined
hyperventilation and intravenous bicarbonate. Am J Emerg Med.
1992;10:553–555.
Olson KR, Kearney TE, Dyer JE, Benowitz NL, Blanc PD. Seizures
associated with poisoning and drug overdose. Am J Emerg Med.
1994;12:392–395.
Dart RC, Borron SW, Caravati EM, et al. Expert consensus guidelines for
stocking of antidotes in hospitals that provide emergency care. Ann Emerg
Med. 2009;54:386–394.
Proudfoot AT, Krenzelok EP, Vale JA. Position paper on urine alkalinization. J
Toxicol Clin Toxicol. 2004;42:1–26.
Garrettson LK, Geller RJ. Acid and alkaline diuresis: when are they of value
in the treatment of poisoning? Drug Saf. 1990;5:220–232.
Temple AR. Acute and chronic effects of aspirin toxicity and their treatment.
Arch Intern Med. 1981;141(3 Spec No):364–369.
Kulling P, Persson H. Role of the intensive care unit in the management of
the poisoned patient. Med Toxicol. 1986;1:375–386.
Alapat PM, Zimmerman JL. Toxicology in the critical care unit. Chest.
2008;133:1006–1013.
Chyka PA, Erdman AR, Christianson G, et al. Salicylate poisoning: an
evidence-based consensus guideline for out-of-hospital management. Clin
Toxicol (Phila). 2007;45:95–131.
Clarke A, Walton WW. Effect of safety packaging on aspirin ingestion by
children. Pediatrics. 1979;63:687–693.
Done AK, Temple AR. Treatment of salicylate poisoning. Mod Treat.
1971;8:528–551.
Done AK. Aspirin overdosage: incidence, diagnosis, and management.
Pediatrics. 1978;62(5, pt 2 Suppl):890–897.
Yip L, Dart RC, Gabow PA. Concepts and controversies in salicylate toxicity.
Emerg Med Clin North Am. 1994;12:351–364.
Notarianni L. A reassessment of the treatment of salicylate poisoning. Drug
Saf. 1992;7:292–303.
Temple AR. Pathophysiology of aspirin overdosage toxicity, with implications
for management. Pediatrics. 1978;62(5, pt 2 Suppl):873–876.
Heffner JE, Sahn SA. Salicylate-induced pulmonary edema: clinical features
and prognosis. Ann Intern Med. 1981;95:405–409.
https://t.me/medicina_free
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
Anderson RJ, Potts DE, Gabow PA, Rumack BH, Schrier RW. Unrecognized
adult salicylate intoxication. Ann Intern Med. 1976;85:745–748.
Bailey RB, Jones SR. Chronic salicylate intoxication: a common cause of
morbidity in the elderly. J Am Geriatr Soc. 1989;37:556–561.
Done AK. Salicylate intoxication: significance of measurements of salicylate
in blood in cases of acute ingestion. Pediatrics. 1960;26:800–807.
Greenberg MI, Hendrickson RG, Hofman M. Deleterious effects of
endotracheal intubation in salicylate poisoning. Ann Emerg Med.
2003;41:583–584.
Dargan PI, Wallace CI, Jones AL. An evidence based flowchart to guide the
management of acute salicylate (aspirin) overdose. Emerg Med J.
2002;19:206–209.
Koren G. Medications which can kill a toddler with one tablet or teaspoonful.
J Toxicol Clin Toxicol. 1993;31:407–413.
Litovitz T, Manoguerra A. Comparison of pediatric poisoning hazards: an
analysis of 3.8 million exposure incidents: a report from the American
Association of Poison Control Centers. Pediatrics. 1992;89(6, pt 1):999–
1006.
Drug Facts and Comparisons [electronic version]. Wolters Kluwer Health,
Inc. Accessed October 9, 2020.
https://www.wolterskluwer.com/en/solutions/lexicomp/facts-and-comparisons
Prescribers Digital Reference: PDR® Network, LLC [electronic version]. IBM
Watson Health. Accessed October 9, 2020. www.micromedexsolutions.com
or www.pdr.net
IBM Micromedex® Drug Identification® [electronic version]. IBM Watson
Health Accessed October 9, 2020. www.micromedexsolutions.com
Rxlist.com. Pill identification tool. Accessed October 9, 2020.
http://www.rxlist.com/
Drugs.com. Drug information online. Accessed October 9, 2020.
http://www.drugs.com/
Manoguerra AS, Erdman AR, Booze LL, et al. Iron ingestion: an evidencebased consensus guideline for out-of-hospital management. Clin Toxicol
(Phila). 2005;43:553–570.
Klein-Schwartz W, Oderda GM, Gorman RL, Favin F, Rose SR. Assessment
of management guidelines: acute iron ingestion. Clin Pediatr (Phila).
1990;29:316–321.
Fine JS. Iron poisoning. Curr Probl Pediatr. 2000;30:71–90.
McGuigan MA. Acute iron poisoning. Pediatr Ann. 1996;25:33–38.
Mills KC, Curry SC. Acute iron poisoning. Emerg Med Clin North Am.
1994;12:397–413.
Banner W Jr, Tong TG. Iron poisoning. Pediatr Clin North Am. 1986;33:393–
409.
https://t.me/medicina_free
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
114.
Caravati EM. Safety of childhood acetaminophen overdose [letter]. Ann
Emerg Med. 2001;37:115–116.
Woolf AD, Erdman AR, Nelson LS, et al. Tricyclic antidepressant poisoning:
an evidence-based consensus guideline for out-of-hospital management.
Clin Toxicol (Phila). 2007;45:203–233.
Jaeger RW, Decastro FJ, Barry RC, Gerren LJ, Brodeur AE. Radiopacity of
drugs and plants in vivo limited usefulness. Vet Hum Toxicol. 1981;23(Suppl
1):2–5.
James JA. Acute iron poisoning: assessment of severity and prognosis. J
Pediatr. 1970;77:117–119.
Perrone J, Hoffman RS, Goldfrank LR, et al. Special considerations in
gastrointestinal decontamination. Emerg Med Clin North Am. 1994;12:285–
299.
Tenebein M. Whole bowel irrigation in iron poisoning. J Pediatr.
1987;111:142–145.
Chyka PA, Butler AY, Holley JE. Serum iron concentrations and symptoms of
acute iron poisoning in children. Pharmacotherapy. 1996;16:1053–1058.
Lovejoy FH Jr. Chelation therapy in iron poisoning. J Toxicol Clin Toxicol.
1982;19:871–874.
Engle JP, Polin KS, Stile IL. Acute iron intoxication: treatment controversies.
Drug Intell Clin Pharm. 1987;21:153–159.
Helfer RE, Rodgerson DO. The effect of deferoxamine on the determination
of serum iron and iron-binding capacity. J Pediatr. 1966;68:804–806.
Ingelfinger JA, Isakson G, Shine D, Costello CE, Goldman P. Reliability of
the toxic screen in drug overdose. Clin Pharmacol Ther. 1981;29:570–575.
Rogers SC, Pruitt CW, Crouch DJ, Caravati EM. Rapid urine drug screens:
diphenhydramine and methadone cross-reactivity. Pediatr Emerg Care.
2010;26:665–666.
Brahm NC, Yeager LL, Fox MD, Farmer KC, Palmer TA. Commonly
prescribed medications and potential false-positive urine drug screens. Am J
Health Syst Pharm. 2010;67:1344–1350.
Yealy DM, Paris PM, Kaplan RM, Heller MB, Marini SE. The safety of
prehospital naloxone administration by paramedics. Ann Emerg Med.
1990;19:902–905.
Watson AJ, Walker JF, Tomkin GH, Finn MM, Keogh JA. Acute Wernickes
encephalopathy precipitated by glucose loading. Ir J Med Sci. 1981;150:301–
303.
Zubaran C, Fernandes JG, Rodnight R. Wernicke-Korsakoff syndrome.
Postgrad Med J. 1997;73:27–31.
Handal KA, Schauben JL, Salamone FR. Naloxone. Ann Emerg Med.
1983;12:438–445.
Lora-Tamayo C, Tena T, Rodriguez A. Cocaine-related deaths. J Chromatogr
A. 1994;674:217–224.
https://t.me/medicina_free
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
128.
129.
130.
131.
132.
133.
Weinbroum A, Rudick V, Sorkine P, et al. Use of flumazenil in the treatment
of drug overdose: a double-blind and open clinical study in 110 patients. Crit
Care Med. 1996;24:199–206.
Forsberg S, Höjer J, Enander C, Ludwigs U. Coma and impaired
consciousness in the emergency room: characteristics of poisoning versus
other causes. Emerg Med J. 2009;26:100–102.
Callaham M. Tricyclic antidepressant overdose. JACEP. 1979;8:413–425.
Ettinger NA, Albin RJ. A review of the respiratory effects of smoking cocaine.
Am J Med. 1989;87:664–668.
Finkle BS, McCloskey KL. The forensic toxicology of cocaine (1971–1976). J
Forensic Sci. 1978;23:173–189.
Kline JN, Hirasuna JD. Pulmonary edema after freebase 3 cocaine smoking
—not due to an adulterant. Chest. 1990;97:1009–1010.
Cucco RA, Yoo OH, Cregler L, Chang JC. Nonfatal pulmonary edema after
“freebase” cocaine smoking. Am Rev Respir Dis. 1987;136:179–181.
Duberstein JL, Kaufman DM. A clinical study of an epidemic of heroin
intoxication and heroin-induced pulmonary edema. Am J Med. 1971;51:704–
714.
Warner-Smith M, Darke S, Day C. Morbidity associated with non-fatal heroin
overdose. Addiction. 2002;97:963–967.
Sporer KA, Dorn E. Heroin-related noncardiogenic pulmonary edema. Chest.
2001;120:1628–1632.
Chan TC, Evans SD, Clark RF. Drug-induced hyperthermia. Crit Care Clin.
1997;13:785–808.
Albertson TE, Fisher CJ Jr, Shragg TA, Baselt RC. A prolonged severe
intoxication after ingestion of phenytoin and phenobarbital. West J Med.
1981;135:418–422.
Adams BK, Mann MD, Aboo A, Isaacs S, Evans A. Prolonged gastric
emptying half-time an gastric hypomotility after drug overdose. Am J Emerg
Med. 2004;22:548–554.
Knopp R. Caustic ingestions. JACEP. 1979;8:329–336.
Dawson AH, Whyte IM. Therapeutic drug monitoring in drug overdose. Br J
Clin Pharmacol. 1999;48:278–283.
Hoffman RJ, Nelson L. Rational use of toxicology testing in children. Curr
Opin Pediatr. 2001;13:183–188.
Rayburn W, Aronow R, DeLancey B, Hogan MJ. Drug overdose during
pregnancy: an overview from a metropolitan poison control center. Obstet
Gynecol. 1984;64:611–614.
Perrone J, Hoffman RS. Toxic ingestions in pregnancy: abortifacient use in a
case series of pregnant overdose patients. Acad Emerg Med. 1997;4:206–
209.
Crome P. Poisoning due to tricyclic antidepressant overdosage: clinical
presentation and treatment. Med Toxicol. 1986;1:261–285.
https://t.me/medicina_free
134.
135.
136.
137.
138.
139.
140.
141.
142.
143.
144.
145.
146.
147.
148.
149.
150.
Callaham M, Kassel D. Epidemiology of fatal tricyclic antidepressant
ingestion: implications of management. Ann Emerg Med. 1985;14:1–9.
Dziukas L, Cameron P. Management of antidepressants in overdose. CNS
Drugs. 1994;2:367–380.
Frommer DA, Kulig KW, Marx JA, Rumack B. Tricyclic antidepressant
overdose: a review. JAMA. 1987;257:521–526.
Guharoy SR. Adult respiratory distress syndrome associated with
amitriptyline overdose. Vet Hum Toxicol. 1994;36:316–317.
Shannon M, Lovejoy FH Jr. Pulmonary consequences of severe tricyclic
antidepressant ingestion. J Toxicol Clin Toxicol. 1987;25:443–461.
Sohn D, Byers J 3rd. Cost effective drug screening in the laboratory. Clin
Toxicol. 1981;18:459–469.
Garriott JC. Interpretive toxicology. Clin Lab Med. 1983;3:367–384.
Henry JA. Epidemiology and relative toxicity of antidepressant drugs in
overdose. Drug Saf. 1997;16:374–390.
Phillips S, Brent J, Kulig K, Heiligenstein J, Birkett M. Fluoxetine versus
tricyclic antidepressants: a prospective multicenter study of antidepressant
drug overdoses. The Antidepressant Study Group. J Emerg Med.
1997;15:439–445.
Singh N, Singh HK, Khan IA. Serial electrocardiographic changes as a
predictor of cardiovascular toxicity in acute tricyclic antidepressant overdose.
Am J Ther. 2002;9:75–79.
Pentel P, Benowitz N. Efficacy and mechanism of action of sodium
bicarbonate in the treatment of desipramine toxicity in rats. J Pharmacol Exp
Ther. 1984;230:12–19.
Shannon M, Liebelt EL. Targeted management strategies for cardiovascular
toxicity from tricyclic antidepressant overdose: the pivotal role for
alkalinization and sodium loading. Pediatr Emerg Care. 1998;14:293–298.
Kingston ME. Hyperventilation in tricyclic antidepressant poisoning. Crit Care
Med. 1979;7:550–551.
Wrenn K, Smith BA, Slovis CM. Profound alkalemia during treatment of
tricyclic antidepressant overdose: a potential hazard of combined
hyperventilation and intravenous bicarbonate. Am J Emerg Med.
1992;10:553–555.
Seger DL, Hantsch C, Zavoral T, Wrenn K. Variability of recommendations for
serum alkalinization in tricyclic antidepressant overdose: a survey of U.S.
poison center medical directors. J Toxicol Clin Toxicol. 2003;41:331–338.
Kozer E, Koren G. Management of paracetamol overdose: current
controversies. Drug Saf. 2001;24:503–512.
Davis M, Simmons CJ, Harrison NG, Williams R. Paracetamol overdose in
man: relationship between pattern of urinary metabolites and severity of liver
damage. Q J Med. 1976;45:181–191.
https://t.me/medicina_free
151.
152.
153.
154.
155.
156.
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
Corcoran GB, Mitchell JR, Vaishnav YN, Horning EC. Evidence that
acetaminophen and N-hydroxyacetaminophen form a common arylating
intermediate, N-acetyl-p-benzoquinoneimine. Mol Pharmacol. 1980;18:536–
542.
Zed PJ, Krenzelok EP. Treatment of acetaminophen overdose. Am J Health
Syst Pharm. 1999;56:1081–1091.
Lester D, Beck AT. Attempted suicide and pregnancy. Am J Obstet Gynecol.
1988;158:1084–1085.
Czeizel A, Lendvay A. Attempted suicide and pregnancy [letter]. Am J Obstet
Gynecol. 1989;161:497.
Riggs BS, Bronstein AC, Kulig K, Archer PG, Rumack BH. Acute
acetaminophen overdose during pregnancy. Obstet Gynecol. 1989;74:247–
253.
Rollins DE, von Bahr C, Glaumann H, Moldéus P, Rane A. Acetaminophen:
potentially toxic metabolite formed by human fetal and adult liver microsomes
and isolated fetal liver cells. Science. 1979;205:1414–1416.
McElhatton PR, Sullivan FM, Volans GN, Fitzpatrick R. Paracetamol
poisoning in pregnancy: an analysis of the outcomes of cases referred to the
Teratology Information Service of the National Poisons Information Service.
Hum Exp Toxicol. 1990;9:147–153.
Prescott LF, Roscoe P, Wright N, Brown SS. Plasma-paracetamol half-life
and hepatic necrosis in patients with paracetamol overdosage. Lancet.
1971;1:519–522.
Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics.
1975;55:871–876.
Anker AL, Smilkstein MJ. Acetaminophen: concepts and controversies.
Emerg Med Clinic North Am. 1994;12:335–349.
Acetaminophen (N-Acetyl-P-Aminophenol, APAP). Drug Facts and
Comparisons. Facts and Comparisons [database online]. Wolters Kluwer
Health; September 2020. Accessed October 9, 2020.
https://www.wolterskluwer.com/en/solutions/lexicomp/facts-and-comparisons
Rumack BH, Peterson RC, Koch GG, Amara IA. Acetaminophen overdose:
662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med.
1981;141(3, Spec No):380–385.
Linden CH, Rumack BH. Acetaminophen overdose. Emerg Med Clinic North
Am. 1984;2:103–119.
Prescott L. Oral or intravenous N-acetylcysteine for acetaminophen
poisoning? Ann Emerg Med. 2005;45:409–413.
Prescott LF. Treatment of severe acetaminophen poisoning with intravenous
acetylcysteine. Arch Intern Med. 1981;141(3, Spec No):386–389.
Acetadote (acetylcysteine) injection labeling. Product information.
Cumberland Pharmaceuticals; 2006.
https://t.me/medicina_free
167.
168.
169.
170.
171.
172.
173.
174.
175.
176.
177.
178.
179.
180.
181.
Smilkstein MJ, Bronstein AC, Linden C, Augenstein WL, Kulig KW, Rumack
BH. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine
treatment protocol. Ann Emerg Med. 1991;20:1058–1063.
Bailey B, McGuigan MA. Management of anaphylactoid reactions to
intravenous N-acetylcysteine. Ann Emerg Med. 1998;31:710–715.
Kerr F, Dawson A, Whyte IM, et al. The Australasian Clinical Toxicology
Investigators Collaboration randomized trial of different loading infusion rates
of N-acetylcysteine. Ann Emerg Med. 2005;45:402–408.
Buckley NA, Whyte IM, O'Connell DL, Dawson AH. Oral or intravenous Nacetylcysteine: which is the treatment of choice for acetaminophen
(paracetamol) poisoning? J Toxicol Clin Toxicol. 1999;37:759–767.
Woo OF, Mueller PD, Olson KR, Anderson IB, Kim SY. Shorter duration of
oral N-acetylcysteine therapy for acute acetaminophen overdose. Ann Emerg
Med. 2000;35:363–368.
Yip L, Dart RC. A 20-hour treatment for acute acetaminophen overdose. N
Engl J Med. 2003;348:2471–2472.
Clarke S, Herren K. Towards evidence based emergency medicine: best
BETs from the Manchester Royal Infirmary. Oral or intravenous antidote for
paracetamol overdose. Emerg Med J. 2002;19:247–248.
Perry HE, Shannon MW. Efficacy of oral versus intravenous N-acetylcysteine
in acetaminophen overdose: results of an open-label clinical trial. J Pediatr.
1998;132:149–152.
Yarema MC, Johnson DW, Berlin RJ, et al. Comparison of the 20-hour
intravenous and 72-hour oral acetylcysteine protocols for the treatment of
acute acetaminophen poisoning. Ann Emerg Med. 2009;54:606–614.
Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral Nacetylcysteine in the treatment of acetaminophen overdose: analysis of the
national multicenter study (1976–1985). N Engl J Med. 1988;319:1557–1562.
Doyon S, Klein-Schwartz W. Hepatotoxicity despite early administration of
intravenous N-acetylcysteine for acute acetaminophen overdose. Acad
Emerg Med. 2009;16:34–39.
Bernal W, Wendon J, Rela M, Heaton N, Williams R. Use and outcome of
liver transplantation in acetaminophen-induced acute liver failure.
Hepatology. 1998;27:1050–1055.
Mitchell I, Bihari D, Chang R, Wendon J, Williams R. Earlier identification of
patients at risk from acetaminophen-induced acute liver failure. Crit Care
Med. 1998;26:279–284.
Gow PJ, Smallwood RA, Angus PW. Paracetamol overdose in a liver
transplantation centre: an 8-year experience. J Gastroenterol Hepatol.
1999;14:817–821.
Harrison PM, O'Grady JG, Keays RT, Alexander GJ, Williams R. Serial
prothrombin time as prognostic indicator in paracetamol induced fulminant
hepatic failure. BMJ. 1990;301:964–966.
https://t.me/medicina_free
182.
183.
184.
Kociancic T, Reed MD. Acetaminophen intoxication and length of treatment:
how long is long enough. Pharmacotherapy. 2003;23:1052–1059.
Wright RO, Anderson AC, Lesko SL, Woolf AD, Linakis JG, Lewander WJ.
Effect of metoclopramide dose on preventing emesis after oral administration
of N-acetylcysteine for acetaminophen overdose. J Toxicol Clin Toxicol.
1999;37:35–42.
Reed MD, Marx CM. Ondansetron for treating nausea and vomiting in the
poisoned patient. Ann Pharmacother. 1994;28:331–333.
https://t.me/medicina_free
1
2
6
End-of-Life Care
Victoria F. Ferraresi and Mary Mihalyo
CORE PRINCIPLES
CHAPTER CASES
End-of-life care consists of palliative and
hospice care. It is ideally introduced
early in the disease progression to
provide support to patients of all ages
with a serious chronic or life-threatening
illness. Medicare patients who enter a
hospice program agree to relinquish
their regular Medicare benefits because
they relate to the terminal illness and
accept the palliative rather than the
curative approach that will be provided
by hospice. Hospice provides all care
related to the hospice diagnosis under a
managed-care model at a fixed
reimbursement.
Case 6-1 (Question 1)
In 2008, the Hospice Conditions of
Participation were updated to include a
Case 6-1 (Question 2)
https://t.me/medicina_free
Соседние файлы в папке Библиотека им академика М.И. Перельмана